Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: Rexall Sundown

This article was originally published in The Tan Sheet

Executive Summary

Rexall Sundown: Sells Pennex Labs facility and equipment to Wayne, Penn.-based Oakmont Pharmaceuticals for cash and a short-term secured note. Rexall Sundown expects to liquidate the remaining assets of Pennex by the end of fiscal 1996 (ending Aug. 31). Oakmont plans to specialize in the development and production of generic OTC and prescription drugs. The firm is expected to spend about $7.2 mil. to acquire and renovate the Pennex plant and equipment. Oakmont is about to be acquired by Hygenics Pharmaceuticals; the firms signed a letter of intent in January...
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS084796

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel